Clinical Trials on Breast Cancer Prevent in Germany
Total 2511 results
-
German Breast GroupRoche Pharma AG; Celgene CorporationCompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
German Breast GroupCelgene Corporation; AmgenCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
Palleos Healthcare GmbHRoche Pharma AG; University Hospital, Essen; University Hospital Erlangen; Phaon...Active, not recruitingTriple-negative Breast CancerGermany
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingTNBC - Triple-Negative Breast CancerGermany
-
Technical University of MunichEli Lilly and CompanyRecruitingBreast Cancer/ Metastatic Breast CancerGermany
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor PharmaCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; iOMEDICO AGCompletedHer2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast CancerGermany
-
Heidelberg UniversityDafra Pharma; Hector-Stiftung; Monika-Kutzner Stiftung, Berlin, Germany; HEIFAN-Heidelberger...CompletedMetastatic Breast Cancer | Locally Advanced Breast CancerGermany
-
German Breast GroupPfizerCompletedMale Breast CancerGermany
-
German Breast GroupCompleted
-
German Breast GroupTerminatedMetastatic Breast CancerGermany
-
German Breast GroupCompletedBreast Cancer MetastaticGermany
-
University of JenaCompleted
-
iOMEDICO AGRoche Pharma AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis...CompletedMetastatic Breast CancerGermany
-
NovartisCompletedMetastatic Breast CancerGermany
-
Kliniken Essen-MitteRecruitingPrimary Breast CancerGermany
-
Prof. W. JanniRoche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbHRecruiting
-
University Hospital TuebingenPaul Ehrlich Institute, Langen, GermanyCompletedMetastatic Breast CancerGermany
-
West German Study GroupCelgeneActive, not recruiting
-
Kliniken Essen-MitteRecruitingBreast Cancer | Node-positive Breast CancerGermany
-
RWTH Aachen UniversityUniv.-Prof. Dr. med. F. KiesslingUnknown
-
Institut fuer FrauengesundheitEisai GmbHRecruitingAssessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (AIRE)Breast Cancer Female | Breast Cancer Metastatic | Neoplasm, BreastGermany
-
German Breast GroupBoehringer IngelheimCompleted
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerGermany
-
RWTH Aachen UniversityRecruiting
-
BioNTech SESeventh Framework ProgrammeCompletedBreast Cancer (Triple Negative Breast Cancer (TNBC))Sweden, Germany
-
German Breast GroupTerminatedMetastatic Breast CancerGermany
-
iOMEDICO AGAmgen; Arbeitsgemeinschaft fur Internistische OnkologieWithdrawnAdvanced Breast Cancer | HER2-positive Breast CancerGermany
-
West German Study GroupSanofi; AmgenCompletedPrimary Breast Cancer | Her2 Non-overexpressingGermany
-
German Breast GroupGlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USACompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
University Hospital TuebingenCompletedBreast Cancer SurgeryGermany
-
German Breast GroupCompletedMetastatic Breast CancerGermany
-
WiSP Wissenschaftlicher Service Pharma GmbHBristol-Myers Squibb; Roche Pharma AGCompleted
-
German Breast GroupAstraZeneca; CelgeneCompleted
-
German Breast GroupRoche Pharma AGRecruitingHER2-positive Breast CancerGermany
-
Novartis PharmaceuticalsRoche - Prof. Dr. Jens Huober et al.TerminatedMetastatic Breast CancerGermany
-
West German Study GroupTeva Pharmaceuticals USAActive, not recruitingEarly Primary Breast CancerGermany
-
Philipps University Marburg Medical CenterUniversitätsklinikum Hamburg-Eppendorf; University of Hamburg-EppendorfUnknownFemale Breast CancerGermany
-
Gesellschaft fur Medizinische Innovation - Hamatologie...iOMEDICO AGCompletedMetastatic Breast CancerGermany
-
Claudia Lorenz-SchlüterTerminatedMetastatic Breast CancerGermany
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingHormone Receptor Positive HER-2 Negative Breast CancerGermany
-
German Breast GroupPfizer; AMS Advanced Medical Services GmbHRecruitingMetastatic Breast CancerGermany
-
German Breast GroupGerman Adjuvant Breast Cancer GroupCompleted
-
Novartis PharmaceuticalsTerminatedPrimary Hormone Receptor Negative Breast Cancer in Premenopausal WomenGermany
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.Not yet recruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | Hormone Receptor Positive HER-2 Negative Breast Cancer | Advanced or Metastatic Breast CancerGermany
-
Philipps University Marburg Medical CenterUnknownFemale Breast CancerGermany
-
German Breast GroupNovartisTerminatedMetastatic Breast CancerGermany
-
iOMEDICO AGCompleted
-
Kliniken Essen-MitteGerman Breast GroupCompletedEarly Stage Breast CancerGermany
-
Heidelberg UniversityVerein für Krebsforschung, Arlesheim, Swizzerland; Weleda AG, D-73525 Schwäbisch...CompletedMetastatic Breast CancerGermany